Literature DB >> 32155903

Special Issue: Nanobody.

Patrick Chames1, Ulrich Rothbauer2,3.   

Abstract

Since their first description in 1993 [1], single-domain antibody fragments derived from heavy-chain-only antibodies of camelids have received increasing attention as highly versatile binding molecules in the fields of biotechnology and medicine [...].

Entities:  

Year:  2020        PMID： 32155903     DOI： 10.3390/antib9010006

Source DB:  PubMed          Journal:  Antibodies (Basel)        ISSN： 2073-4468


  2 in total

Review 1.  Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19).

Authors:  Salma Bessalah; Samira Jebahi; Naceur Mejri; Imed Salhi; Touhami Khorchani; Mohamed Hammadi
Journal:  3 Biotech       Date:  2021-01-22       Impact factor: 2.406

Review 2.  Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.

Authors:  Norma A Valdez-Cruz; Enrique García-Hernández; Clara Espitia; Laura Cobos-Marín; Claudia Altamirano; Carlos G Bando-Campos; Luis F Cofas-Vargas; Enrique W Coronado-Aceves; Ricardo A González-Hernández; Pablo Hernández-Peralta; Daniel Juárez-López; Paola A Ortega-Portilla; Sara Restrepo-Pineda; Patricio Zelada-Cordero; Mauricio A Trujillo-Roldán
Journal:  Microb Cell Fact       Date:  2021-04-22       Impact factor: 5.328
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.